Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Fulgent Genetics, Inc. operates as a technology company. The Company develops a proprietary technology platform that integrates sophisticated data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes. Fulgent Genetics offers genetic testing to provide physicians with clinically diagnostic information.
Website: fulgentgenetics.com



Growth: Good revenue growth rate 16.7%, there is acceleration compared to average historical growth rates -14.5%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -81.0%

Profitability: LTM EBITDA margin is negative, -14.9%. On average the margin is improving steadily. Gross margin is high, +42.2%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.37 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 67.6% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 80.2% higher than minimum and 32.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.5x by EV / Sales multiple , the company can be >100% undervalued

Insiders: For the last 3 months insiders sold company shares on $0.5 mln (-0.051% of cap.)

Key Financials (Download financials)

Ticker: FLGT
Share price, USD:  (0.0%)27.53
year average price 21.80  


year start price 16.14 2025-02-07

min close price 15.28 2025-03-03

max close price 30.85 2025-11-25

current price 27.53 2026-02-07
Common stocks: 30 749 000

Dividend Yield:  0.0%
EV / Sales: 0.2x
Margin (EBITDA LTM / Revenue): -14.9%
Fundamental value created in LTM:
Market Cap ($m): 847
Net Debt ($m): -788
EV (Enterprise Value): 59
Price to Book: 0.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-23zacks.com

FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform

2025-12-22businesswire.com

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

2025-11-07businesswire.com

Fulgent Reports Third Quarter 2025 Financial Results

2025-08-02fool.com

Fulgent (FLGT) Q2 Revenue Jumps 16%

2025-08-01zacks.com

Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates

2025-06-16accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT

2025-06-06globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

2025-05-28globenewswire.com

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. (NASDAQ: FLGT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

2025-05-24businesswire.com

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

2025-05-22globenewswire.com

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2023-11-03 2023-08-04 2023-05-05 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2025-02-28 07:15:43 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02 2022-02-28 08:13:11 2021-03-08 17:17:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 84M 82M 283M 72M 71M 64M 289M 85M 68M 66M 619M 106M 993M 422M
costOfRevenue 49M 47M 176M 45M 47M 44M 185M 45M 47M 47M 252M 60M 216M 90M
grossProfit 36M 34M 107M 27M 25M 20M 104M 40M 21M 19M 367M 46M 777M 332M
grossProfitRatio 0.422 0.421 0.373 0.345 0.312 0.47 0.303 0.284 0.436
researchAndDevelopmentExpenses 14M 13M 49M 12M 13M 11M 41M 10M 10M 10M 29M 8M 24M 12M
generalAndAdministrativeExpenses 23M 26M 88M 21M 21M 21M 89M 17M 18M 22M 111M 26M 51M 15M
sellingAndMarketingExpenses 12M 12M 36M 9M 9M 9M 41M 10M 11M 10M 39M 10M 24M 15M
sellingGeneralAndAdministrativeExpenses 35M 39M 124M 30M 30M 30M 130M 28M 29M 32M 150M 36M 75M 30M
otherExpenses 2M 2M 8M 2M 2M 0 128M 2M 2M 2M 9M 2M 2M 0
operatingExpenses 51M 54M 181M 44M 43M 42M 300M 40M 40M 44M 188M 46M 101M 42M
costAndExpenses 99M 102M 357M 89M 90M 86M 485M 84M 88M 91M 440M 105M 317M 132M
interestIncome 8M 8M 31M 8M 8M 8M 22M 7M 5M 4M 6M 1M 1M 2M
interestExpense 28 000 17 000 170 000 14 000 0 0 488 000 54 000 206 000 -4M 1M 1M 0 0
depreciationAndAmortization 6M 6M 25M 6M 6M 7M 26M 6M 6M 2M 33M 2M 11M 3M
ebitda -77 001 -15M -49M -17M -13M -15M -147M 7M -13M -23M 218M 3M 687M 293M
ebitdaratio -0.001 -0.189 -0.238 -0.18 -0.235 0.078 -0.199 -0.345 0.024
operatingIncome -15M -20M -74M -17M -19M -22M -196M 214 000 -20M -25M 179M 562 000 676M 290M
operatingIncomeRatio -0.183 -0.241 -0.238 -0.266 -0.338 0.003 -0.292 -0.375 0.005
totalOtherIncomeExpensesNet 9M -2M 22M -1M 8M 8M 21M 7M 5M 4M 5M 1M 5M -3M
incomeBeforeTax -6M -22M -52M -19M -11M -14M -174M 7M -15M -21M 184M 2M 681M 287M
incomeBeforeTaxRatio -0.073 -0.263 -0.258 -0.158 -0.22 0.081 -0.217 -0.318 0.017
incomeTaxExpense 682 999 -2M -8M -4M -2M -327 000 1M 20M -3M -5M 42M 414 000 175M 73M
netIncome -7M -19M -43M -15M -9M -13M -168M -13M -11M -16M 143M 1M 507M 214M
netIncomeRatio -0.079 -0.232 -0.204 -0.123 -0.209 -0.155 -0.165 -0.24 0.013
eps -0.21 -0.61 -1.41 -0.48 -0.29 -0.45 -5.63 -0.44 -0.38 -0.54 4.76 0.045 17.13 9.44
epsdiluted -0.21 -0.61 -0.48 -0.29 -0.45 -0.44 -0.38 -0.54 0.044
weightedAverageShsOut 31M 31M 30M 30M 30M 30M 30M 30M 30M 30M 30M 30M 29M 23M
weightedAverageShsOutDil 31M 31M 30M 30M 30M 30M 30M 30M 30M 30M 31M 31M 31M 24M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-28 2023-02-28 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 31M 21M 5M 1M 2M
ebit -74M -174M 185M 676M 290M
nonOperatingIncomeExcludingInterest 0 -22M -7M 0 0
netIncomeFromContinuingOperations -44M -175M 142M 506M 214M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -43M -168M 143M 507M 214M
epsDiluted -1.41 -5.63 4.63 16.26 8.91

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2023-11-03 2023-08-04 2023-05-05 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2025-02-28 07:15:43 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02 2022-02-28 08:13:11 2021-03-08 17:17:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 118M 88M 55M 58M 65M 55M 97M 84M 58M 66M 80M 169M 165M 87M
shortTermInvestments 258M 205M 203M 155M 247M 251M 327M 384M 400M 805M 447M 749M 286M 212M
cashAndShortTermInvestments 376M 293M 258M 213M 312M 306M 424M 468M 458M 871M 526M 918M 450M 299M
netReceivables 79M 85M 77M 57M 64M 59M 57M 55M 40M 44M 75M 104M 143M 204M
inventory 10M 9M 8M 9M 7M 7M 0 5M 6M 5M 4M 8M 12M 16M
otherCurrentAssets 43M 42M 0 48M 17M 21M 6M 33M 35M 33M 0 10M 0 0
totalCurrentAssets 507M 429M 354M 327M 399M 387M 508M 550M 528M 915M 628M 1 022M 612M 524M
propertyPlantEquipmentNet 112M 110M 106M 107M 103M 96M 96M 85M 88M 79M 81M 82M 62M 40M
goodwill 25M 22M 22M 22M 22M 22M 22M 142M 142M 143M 143M 120M 51M 0
intangibleAssets 135M 131M 135M 137M 139M 141M 143M 144M 146M 149M 151M 88M 36M 0
goodwillAndIntangibleAssets 160M 153M 157M 159M 161M 163M 165M 286M 288M 292M 294M 208M 87M 0
longTermInvestments 412M 484M 570M 602M 547M 561M 444M 399M 401M 380M 339M 358M 507M 133M
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 23M 23M 33M 39M 23M 23M 23M 38M 49M -289M 44M -265M 11M 4M
totalNonCurrentAssets 707M 771M 866M 907M 833M 843M 727M 809M 826M 462M 758M 384M 667M 177M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 215M 1 200M 1 220M 1 234M 1 232M 1 230M 1 235M 1 358M 1 355M 1 377M 1 386M 1 406M 1 279M 700M
accountPayables 18M 19M 18M 20M 20M 20M 15M 16M 21M 22M 23M 14M 20M 26M
shortTermDebt 2M 2M 412 000 412 000 3M 4M 1M 3M 5M 21M 21M 20M 21M 15M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 426 000 787 000 53M
deferredRevenue 31M 30M 30M 27M 3M 3M 26M 21M 17M 14M 14M 28M 34M 27M
otherCurrentLiabilities 22M 21M 6M 27M 24M 50M 164 000 21M 23M 51M 5M 61M 11M -185 000
totalCurrentLiabilities 72M 71M 73M 74M 76M 76M 73M 61M 65M 108M 88M 124M 105M 130M
longTermDebt 6M 6M 2M 0 10M 2M 3M 3M 0 0 3M 0 0 0
deferredRevenueNonCurrent 0 0 0 0 8M 7M 0 -3M 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 7M 6M 6M 7M 13M 13M 8M 10M 10M 0 0 0 0 0
otherNonCurrentLiabilities 9M 5M 5M 18M 4M 5M 11M 25M 17M 26M 16M -42M 8M 391 000
totalNonCurrentLiabilities 21M 17M 18M 25M 28M 27M 29M 35M 26M 26M 28M 22M 8M 959 000
otherLiabilities 0 0 0 0 0 0 0 0 0 -26M 0 -22M 0 0
capitalLeaseObligations 5M 5M 6M 0 10M 7M 11M 10M 11M 0 15M 0 0 835 000
totalLiabilities 94M 88M 91M 99M 103M 103M 102M 97M 91M 108M 116M 124M 113M 131M
preferredStock 0 0 0 0 20M 20M 0 15M 13M 13M 0 0 0 0
commonStock 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000
retainedEarnings 553M 560M 590M 596M 611M 620M 633M 761M 774M 786M 801M 825M 658M 151M
accumulatedOtherComprehensiveIncomeLoss 7M 6M -368 000 9M -877 000 -1M 1M -17M -21M -17M -21M -26M -759 000 438 000
othertotalStockholdersEquity 566M 551M 533M 522M 491M 499M 493M 487M 482M
totalStockholdersEquity 1 126M 1 117M 1 133M 1 138M 1 133M 1 130M 1 136M 1 259M 1 260M 1 269M 1 267M 1 281M 1 159M 569M
totalEquity 1 121M 1 112M 1 129M 1 135M 1 129M 1 127M 1 133M 1 262M 1 263M 1 273M 1 270M 1 281M 1 166M 569M
totalLiabilitiesAndStockholdersEquity 1 215M 1 200M 1 234M 1 232M 1 230M 1 358M 1 355M 1 377M 1 406M
minorityInterest -5M -5M -4M -4M -4M -3M -3M 3M 4M 4M 3M 0 7M 0
totalLiabilitiesAndTotalEquity 1 215M 1 200M 1 220M 1 234M 1 232M 1 230M 1 235M 1 358M 1 355M 1 377M 1 386M 1 406M 1 279M 700M
totalInvestments 670M 690M 773M 757M 793M 812M 771M 767M 788M 805M 786M 760M 793M 344M
totalDebt 8M 7M 8M 412 000 13M 13M 15M 3M 5M 21M 39M 20M 21M 16M
netDebt -110M -80M -47M -58M -52M -42M -82M -81M -54M -46M -41M -148M -144M -72M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-28 2023-02-28 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 69M 51M 53M 139M 184M
otherReceivables 8M 6M 22M 4M 20M
prepaids 10M 20M 22M 6M 4M
totalPayables 18M 15M 23M 21M 80M
otherPayables 0 0 0 787 000 53M
accruedExpenses 17M 27M 19M 18M 8M
capitalLeaseObligationsCurrent 1M 4M 6M 0 267 000
capitalLeaseObligationsNonCurrent 4M 7M 9M 0 568 000
treasuryStock 0 0 0 0 0
additionalPaidInCapital 543M 502M 487M 502M 418M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2023-11-03 2023-08-04 2023-05-05 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2025-02-28 07:15:43 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02 2022-02-28 08:13:11 2021-03-08 17:17:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -7M -19M -44M -15M -9M -13M -175M -13M -12M -16M 142M 1M 506M 214M
depreciationAndAmortization 6M 6M 25M 6M 6M 7M 26M 6M 6M 7M 33M 10M 11M 3M
deferredIncomeTax -701 000 24 000 -5M -2M -457 000 -557 000 8M 19M -3M -5M 831 000 3M -8M -1M
stockBasedCompensation 10M 10M 44M 11M 12M 12M 43M 11M 10M 10M 33M 9M 16M 8M
changeInWorkingCapital 2M -39M -7M -2M -3M 5M 3M -11M 9M -5M 2M -11M -3M -91M
accountsReceivables 5M -8M -16M -2M -3M 1M 2M -12M 10M 9M 69M 22M 42M -178M
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0
accountsPayables -102 000 386 000 3M 2M 2M -245 000 -7M -3M -3M -2M -25M -22M -12M 23M
otherWorkingCapital -2M -31M 6M -3M -2M 4M 7M 3M 843 000 -7M -41M -12M -33M 64M
otherNonCashItems 495 000 11M 8M -12M 23M 22M 123M -2M -668 000 791 000 43M 9M 16M 8M
netCashProvidedByOperatingActivities 11M -30M 21M -16M 4M 7M 27M 10M 10M -8M 254M 21M 539M 141M
investmentsInPropertyPlantAndEquipment -6M -7M -40M -20M -13M -4M -22M -5M -12M -2M -19M -5M -24M -37M
acquisitionsNet 0 0 0 -275 000 17 000 258 000 -399 000 22 000 220 000 0 -183M 0 -62M -3M
purchasesOfInvestments -19M 0 -472M -115M -63M -196M -492M -93M -107M -144M -433M -12M -730M -324M
salesMaturitiesOfInvestments 40M 60M 454M 144M 83M 152M 553M 118M 117M 141M 373M 61M 270M 37M
otherInvestingActivites 4M 0 313 000 20M 258 000 25M 0 198 000 222 000
netCashUsedForInvestingActivites 19M 53M 9M 7M -47M 20M -1M -4M 44M
debtRepayment -88 000 -88 000 -136 000 -602 000 -900 000 -2M -16M -232 000 -238 000
commonStockIssued 0 0 0 0 0 0 3000 0 0
commonStockRepurchased -357 000 -3M -3M -431 000 -544 000 -225 000 -28M -2M -232 000 0 -76M -35M -4M -62 000
dividendsPaid 0 0 0 0 0 0 -229 000 0 0
otherFinancingActivites 0 0 0 -544 000 -2M -517 000 229 000 -869 000 -522 000
netCashUsedProvidedByFinancingActivities -445 000 -3M -567 000 -1M -3M -4M -16M -1M -35M
effectOfForexChangesOnCash 15 000 4000 -55 000 157 000 -9000 -69 000 -149 000 -116 000 -206 000 28 000 -453 000 387 000 34 000 20 000
netChangeInCash 30M 21M -42M -7M 10M -43M 18M 26M -8M -13M -85M 30M 77M 75M
cashAtEndOfPeriod 118M 88M 55M 58M 65M 55M 97M 84M 58M 66M 80M 169M 165M 87M
cashAtBeginningOfPeriod 88M 67M 97M 65M 55M 97M 80M 58M 66M 80M 165M 139M 87M 12M
operatingCashFlow 11M -30M 21M -16M 4M 7M 27M 10M 10M -8M 254M 21M 539M 141M
capitalExpenditure -6M -7M -40M -20M -13M -4M -22M -5M -12M -2M -19M -5M -24M -37M
freeCashFlow 5M -37M -19M -35M -9M 3M 5M 5M -2M -10M 235M 15M 515M 104M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-28 2023-02-28 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 313 000 775 000 412 000 31 000 8000
netCashProvidedByInvestingActivities -58M 39M -261M -547M -326M
netDebtIssuance -2M -20M -1M -11 000 15M
longTermNetDebtIssuance -544 000 -730 000 -700 000 -7000 0
shortTermNetDebtIssuance -1M -19M -367 000 -4000 15M
netStockIssuance -3M -28M -76M 85M 246M
netCommonStockIssuance -3M -28M -76M 85M 246M
commonStockIssuance 0 0 0 89M 246M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 51 000 3000 31 000 96 000 104 000
netCashProvidedByFinancingActivities -5M -48M -77M 85M 261M
incomeTaxesPaid 28M 3M 56M 237M 21M
interestPaid 512 000 960 000 0 0 0

Earning call transcript

2025 q3
2025-11-07 ET (fiscal 2025 q3)
2025 q2
2025-08-01 ET (fiscal 2025 q2)
2025 q1
2025-05-02 ET (fiscal 2025 q1)
2024 q4
2025-02-28 ET (fiscal 2024 q4)
2024 q3
2024-11-11 ET (fiscal 2024 q3)
2024 q2
2024-08-02 ET (fiscal 2024 q2)
2024 q1
2024-05-03 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-04 ET (fiscal 2023 q2)
2023 q1
2023-05-05 ET (fiscal 2023 q1)
2022 q4
2023-02-28 ET (fiscal 2022 q4)
2022 q3
2022-11-07 ET (fiscal 2022 q3)
2022 q2
2022-08-04 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-07 07:14 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics reported for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-10-20 10:04 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-10-20 10:04 ET
Fulgent Genetics published news for 2025 q3
SEC form 10
2025-08-01 07:09 ET
Fulgent Genetics reported for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 10
2025-05-02 11:14 ET
Fulgent Genetics published news for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics published news for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics reported for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics published news for 2025 q1
SEC form 10
2025-05-02 00:00 ET
Fulgent Genetics published news for 2025 q1
SEC form 10
2025-02-28 07:15 ET
Fulgent Genetics reported for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 10
2025-02-28 00:00 ET
Fulgent Genetics published news for 2024 q4
SEC form 10
2024-11-08 07:17 ET
Fulgent Genetics reported for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 10
2024-08-02 07:38 ET
Fulgent Genetics published news for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics published news for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics reported for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics published news for 2024 q2
SEC form 10
2024-08-02 00:00 ET
Fulgent Genetics published news for 2024 q2
SEC form 10
2024-05-03 07:34 ET
Fulgent Genetics published news for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics published news for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics reported for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics published news for 2024 q1
SEC form 10
2024-05-03 00:00 ET
Fulgent Genetics published news for 2024 q1
SEC form 10
2024-02-28 17:03 ET
Fulgent Genetics published news for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics published news for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics reported for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Fulgent Genetics published news for 2023 q4
SEC form 10
2023-11-03 07:31 ET
Fulgent Genetics published news for 2023 q3
SEC form 8
2023-11-03 07:09 ET
Fulgent Genetics reported for 2023 q3
SEC form 10
2023-11-03 00:00 ET
Fulgent Genetics published news for 2023 q3
SEC form 10
2023-08-04 07:14 ET
Fulgent Genetics reported for 2023 q2
SEC form 6
2023-08-04 07:07 ET
Fulgent Genetics published news for 2023 q2
SEC form 10
2023-08-04 00:00 ET
Fulgent Genetics published news for 2023 q2
SEC form 8
2023-08-04 00:00 ET
Fulgent Genetics published news for 2023 q2
SEC form 10
2023-05-05 00:00 ET
Fulgent Genetics published news for 2023 q1
SEC form 8
2023-05-05 00:00 ET
Fulgent Genetics published news for 2023 q1
SEC form 10
2023-02-28 16:49 ET
Fulgent Genetics reported for 2022 q4
SEC form 6
2023-02-28 16:24 ET
Fulgent Genetics published news for 2022 q4
SEC form 10
2023-02-28 00:00 ET
Fulgent Genetics reported for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Fulgent Genetics reported for 2022 q4
SEC form 6
2023-01-12 16:10 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2023-01-04 16:34 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2023-01-03 16:11 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2022-11-23 16:09 ET
Fulgent Genetics published news for 2022 q3
SEC form 10
2022-11-07 16:36 ET
Fulgent Genetics reported for 2022 q3
SEC form 6
2022-11-07 16:11 ET
Fulgent Genetics published news for 2022 q3
SEC form 10
2022-11-07 00:00 ET
Fulgent Genetics reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Fulgent Genetics reported for 2022 q3
SEC form 6
2022-11-04 16:05 ET
Fulgent Genetics published news for 2022 q3
SEC form 6
2022-09-29 16:15 ET
Fulgent Genetics published news for 2022 q2
SEC form 6
2022-08-10 18:06 ET
Fulgent Genetics published news for 2022 q2
SEC form 10
2022-08-04 17:03 ET
Fulgent Genetics reported for 2022 q2
SEC form 6
2022-08-04 16:39 ET
Fulgent Genetics published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Fulgent Genetics reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Fulgent Genetics reported for 2022 q2
SEC form 6
2022-08-03 17:34 ET
Fulgent Genetics published news for 2022 q2
SEC form 6
2022-06-30 16:07 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-05-19 16:19 ET
Fulgent Genetics published news for 2022 q1
SEC form 10
2022-05-05 16:51 ET
Fulgent Genetics reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Fulgent Genetics reported for 2022 q1
SEC form 6
2022-05-03 16:10 ET
Fulgent Genetics published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Fulgent Genetics reported for 2022 q1
SEC form 6
2022-04-26 16:43 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-04-18 16:13 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-03-29 16:33 ET
Fulgent Genetics published news for 2021 q4
SEC form 6
2022-03-29 16:23 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2022-02-28 08:13 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Fulgent Genetics published news for 2021 q4
SEC form 6
2022-02-23 16:10 ET
Fulgent Genetics published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2021-11-09 17:13 ET
Fulgent Genetics published news for 2021 q3
SEC form 6
2021-11-09 16:11 ET
Fulgent Genetics published news for 2021 q3
SEC form 10
2021-11-09 00:00 ET
Fulgent Genetics published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Fulgent Genetics published news for 2021 q3
SEC form 10
2021-08-10 00:00 ET
Fulgent Genetics published news for 2021 q2
SEC form 10
2021-08-09 21:32 ET
Fulgent Genetics published news for 2021 q2
SEC form 6
2021-08-09 16:25 ET
Fulgent Genetics published news for 2021 q2
SEC form 6
2021-05-20 17:12 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-05-07 16:07 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Fulgent Genetics published news for 2021 q1
SEC form 6
2021-05-06 16:20 ET
Fulgent Genetics published news for 2021 q1
SEC form 6
2021-04-01 16:16 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-03-08 17:17 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2021-03-04 16:07 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2021-02-05 16:40 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2020-12-22 17:08 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-23 08:12 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-20 17:03 ET
Fulgent Genetics published news for 2020 q3
SEC form 10
2020-11-09 16:24 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-09 16:11 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-10-21 16:17 ET
Fulgent Genetics published news for 2020 q3